In English|Suomeksi
Suomeksi
Extranet
Logo
  • Why Finland
  • Value of medicines
    • Health through innovation
    • Working and functional capacity
    • Savings in overall expenditure
    • Economic growth through the health sector
  • R&D
    • Research environment Finland
    • Research generates wellbeing
    • Pharmaceutical research and product development
    • Clinical trials of medicinal products
    • Register-based studies
    • RWD studies
  • Medicines
    • Hospital medicines
    • Vaccines
      • Development of vaccines
    • Self-care medicines
    • Biological medicines
    • Biosimilars
    • Marketing authorisation
    • Medicine prices
    • Reimbursability of medicines
    • Distribution of pharmaceuticals
  • Responsibility
    • Pharmaceutical manufacturing
    • Medicines safety
    • Medicines verification system
    • Marketing
      • Ground rules for marketing
      • Supervision of pharmaceutical marketing
    • Cooperation with healthcare professionals
    • Medicines and the environment
    • Pharmaceutical industry – branch of top notch experts
    • Joint fight against antibiotic resistance
  • We are
    • We influence
    • This is what we do
    • PIF members
      • Member companies
    • The PIF Board
    • Statistics
  • Newsroom
    • News
    • Blogs
    • Events
    • Statistics
  • Contact
    • Personnel
    • Media contacts
    • Feedback
  • Why Finland
  • Value of medicines
    • Health through innovation
    • Working and functional capacity
    • Savings in overall expenditure
    • Economic growth through the health sector
  • R&D
    • Research environment Finland
    • Research generates wellbeing
    • Pharmaceutical research and product development
    • Clinical trials of medicinal products
    • Register-based studies
    • RWD studies
  • Medicines
    • Hospital medicines
    • Vaccines
      • Development of vaccines
    • Self-care medicines
    • Biological medicines
    • Biosimilars
    • Marketing authorisation
    • Medicine prices
    • Reimbursability of medicines
    • Distribution of pharmaceuticals
  • Responsibility
    • Pharmaceutical manufacturing
    • Medicines safety
    • Medicines verification system
    • Marketing
      • Ground rules for marketing
      • Supervision of pharmaceutical marketing
    • Cooperation with healthcare professionals
    • Medicines and the environment
    • Pharmaceutical industry – branch of top notch experts
    • Joint fight against antibiotic resistance
  • We are
    • We influence
    • This is what we do
    • PIF members
      • Member companies
    • The PIF Board
    • Statistics
  • Newsroom
    • News
    • Blogs
    • Events
    • Statistics
  • Contact
    • Personnel
    • Media contacts
    • Feedback
  • In EnglishSuomeksi
  • Extranet
  • Lääketeollisuus
  • >
  • We are
  • >
  • PIF members
  • >
  • Member companies

We are

  • We influence
  • This is what we do
  • PIF members
  • Member companies
  • The PIF Board
  • Statistics

Member companies

PIF member companies

AbbVie OyAmgen AB, sivuliike SuomessaAstellas Pharma, filial i FinlandAstraZeneca OyBayer OyBerlin-Chemie / A. Menarini Suomi OyBiocodex OyBiogen Finland OyBoehringer Ingelheim Finland KyChiesi Pharma ABDaiichi Sankyo Oncology Nordics ApsFerring Lääkkeet OyFinVector OyFVR - Suomen rokotetutkimusGlaxoSmithKline OyJanssen-Cilag OyIQVIA RDS Finland OyLEO Pharma OyMerck OyMSD Finland OyNanoform Finland OyjNovartis Finland OyNovo Nordisk Farma OyOy Bristol-Myers Squibb (Finland) AbOy Eli Lilly Finland AbOy H. Lundbeck AbOy Medfiles LtdOy Swedish Orphan Biovitrum AbOptimapharm Nordic OyOrganon Finland OyPfizer OyPharmaLex FinlandRoche OySanofi OySanten OyServier Finland OyTakeda OyTFS Trial Form Support OyUCB Pharma Oy Finland
Pharma Industry Finland (PIF) Itämerentori 2 P.O.Box 206 00181 Helsinki, Finland
pif@pif.fi